Warburg Pincus to offload 3.5 mln China Biologic shares in secondary offering

Affiliates of Warburg Pincus agreed to sell 3.5 million shares of China Biologic Products Inc common stock in an underwritten public offering. The shares to be sold represent approximately 13.2 percent of the US-listed biopharmaceutical company's current outstanding shares of common stock. Morgan Stanley is acting as the sole underwriter for the offering.

DealsNorth AmericaUSBriefs